Review



anti igf2 goat polyclonal antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems anti igf2 goat polyclonal antibody
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Anti Igf2 Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti igf2 goat polyclonal antibody/product/R&D Systems
    Average 94 stars, based on 27 article reviews
    anti igf2 goat polyclonal antibody - by Bioz Stars, 2026-06
    94/100 stars

    Images

    1) Product Images from "Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study."

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    Journal: The Journal of clinical endocrinology and metabolism

    doi: 10.1210/jc.2018-00593

    Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Figure Legend Snippet: Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.

    Techniques Used: Comparison

    Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.
    Figure Legend Snippet: Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.

    Techniques Used: Gene Expression, Quantitative RT-PCR, Expressing

    Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.
    Figure Legend Snippet: Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.

    Techniques Used: Expressing, Immunohistochemistry, Comparison



    Similar Products

    anti igf2 goat polyclonal antibody  (R&D Systems)
    94
    R&D Systems anti igf2 goat polyclonal antibody
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Anti Igf2 Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti igf2 goat polyclonal antibody/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    anti igf2 goat polyclonal antibody - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    goat anti human igf2 polyclonal antibody  (R&D Systems)
    94
    R&D Systems goat anti human igf2 polyclonal antibody
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Goat Anti Human Igf2 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti human igf2 polyclonal antibody/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    goat anti human igf2 polyclonal antibody - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    goat polyclonal anti human igf ii  (R&D Systems)
    90
    R&D Systems goat polyclonal anti human igf ii
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Goat Polyclonal Anti Human Igf Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal anti human igf ii/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    goat polyclonal anti human igf ii - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    biotin labeled goat polyclonal anti human igf ii  (R&D Systems)
    85
    R&D Systems biotin labeled goat polyclonal anti human igf ii
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Biotin Labeled Goat Polyclonal Anti Human Igf Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotin labeled goat polyclonal anti human igf ii/product/R&D Systems
    Average 85 stars, based on 1 article reviews
    biotin labeled goat polyclonal anti human igf ii - by Bioz Stars, 2026-06
    85/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    doi: 10.1210/jc.2018-00593

    Figure Lengend Snippet: Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.

    Article Snippet: Sections were also stained with an anti-IGF2 goat polyclonal antibody (AF-292-NA; R&D Systems, Minneapolis, MN) and an anti-PCSK4 rabbit polyclonal antibody (NBP1-88010; Novus Biologicals, Littleton, CO).

    Techniques: Comparison

    Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    doi: 10.1210/jc.2018-00593

    Figure Lengend Snippet: Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.

    Article Snippet: Sections were also stained with an anti-IGF2 goat polyclonal antibody (AF-292-NA; R&D Systems, Minneapolis, MN) and an anti-PCSK4 rabbit polyclonal antibody (NBP1-88010; Novus Biologicals, Littleton, CO).

    Techniques: Gene Expression, Quantitative RT-PCR, Expressing

    Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    doi: 10.1210/jc.2018-00593

    Figure Lengend Snippet: Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.

    Article Snippet: Sections were also stained with an anti-IGF2 goat polyclonal antibody (AF-292-NA; R&D Systems, Minneapolis, MN) and an anti-PCSK4 rabbit polyclonal antibody (NBP1-88010; Novus Biologicals, Littleton, CO).

    Techniques: Expressing, Immunohistochemistry, Comparison